Literature DB >> 16288014

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

Richard D Kennedy1, Julia J Gorski, Jennifer E Quinn, Gail E Stewart, Colin R James, Stephen Moore, Karl Mulligan, Ethan D Emberley, Tong F Lioe, Patrick J Morrison, Paul B Mullan, George Reid, Patrick G Johnston, Peter H Watson, D Paul Harkin.   

Abstract

Evidence is accumulating to suggest that some of the diverse functions associated with BRCA1 may relate to its ability to transcriptionally regulate key downstream target genes. Here, we identify S100A7 (psoriasin), S100A8, and S100A9, members of the S100A family of calcium-binding proteins, as novel BRCA1-repressed targets. We show that functional BRCA1 is required for repression of these family members and that a BRCA1 disease-associated mutation abrogates BRCA1-mediated repression of psoriasin. Furthermore, we show that BRCA1 and c-Myc form a complex on the psoriasin promoter and that BRCA1-mediated repression of psoriasin is dependent on functional c-Myc. Finally, we show that psoriasin expression is induced by the topoisomerase IIalpha poison, etoposide, in the absence of functional BRCA1 and increased psoriasin expression enhances cellular sensitivity to this chemotherapeutic agent. Therefore, we identified a novel transcriptional mechanism that is likely to contribute to BRCA1-mediated resistance to etoposide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288014     DOI: 10.1158/0008-5472.CAN-05-1841

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase.

Authors:  Andrew A Horwitz; El Bachir Affar; George F Heine; Yang Shi; Jeffrey D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

2.  Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.

Authors:  Melinda E Sanders; Eduardo C Dias; Baogang J Xu; James A Mobley; Dean Billheimer; Heinrich Roder; Julia Grigorieva; Mitchell Dowsett; Carlos L Arteaga; Richard M Caprioli
Journal:  J Proteome Res       Date:  2008-04-04       Impact factor: 4.466

Review 3.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 4.  The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression.

Authors:  Suhwan Chang; Shyam K Sharan
Journal:  Transcription       Date:  2012-11-06

Review 5.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

6.  Mammary gland biology and breast cancer. Conference on Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer Progression.

Authors:  Sharon F McGee; Fiona Lanigan; Emer Gilligan; Bernd Groner
Journal:  EMBO Rep       Date:  2006-10-20       Impact factor: 8.807

7.  Large-scale proteomic identification of S100 proteins in breast cancer tissues.

Authors:  Patrizia Cancemi; Gianluca Di Cara; Nadia Ninfa Albanese; Francesca Costantini; Maria Rita Marabeti; Rosa Musso; Carmelo Lupo; Elena Roz; Ida Pucci-Minafra
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

Review 8.  MYC in breast tumor progression.

Authors:  Yinghua Chen; Olufunmilayo I Olopade
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

9.  MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency.

Authors:  Jie Ren; Feng Jin; Zhaojin Yu; Lin Zhao; Lin Wang; Xuefeng Bai; Haishan Zhao; Weifan Yao; Xiaoyi Mi; Enhua Wang; Olufunmilayo I Olopade; Minjie Wei
Journal:  Tumour Biol       Date:  2013-07-17

Review 10.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.